Global HLA Typing For Transplant Market Size, Trends & Growth Opportunity and By Type (Molecular Assays and Non-Molecular Assays), By Application (Diagnostic Applications and Research Applications), By End User (Hospitals & Transplant Centers, Commercial Service Providers, and Research Laboratories and Academic Institutes), By Region and Forecast till 2027.
Global HLA Typing For Transplant Market 
The Global HLA Typing For Transplant Market is expected to grow from US$ 775.5 Million in 2021 to US$ 1234.5 Million by 2027; it is estimated to grow at a CAGR of 8.06% from 2021 to 2027.
Market Overview
HLA typing is commonly referred as Human Leukocyte Antigen which is used to check how closely tissue of donor matches with tissue of recipient before transplantation. HLA are proteins which inherited from the parents.  HLA matching helps in development and growth of new healthy food cells and also eliminates risk of post-transplant complication.
Market Drivers
Rise in number of transplant procedures is the key driving factor which is expected to boost the global HLA typing for transplant market growth. Furthermore, continuous technological advancements in HLA typing will have the positive impact on market growth. Moreover, rise in public-private funding for target research activities will fuel the market growth. In addition to that, increase in geriatric population will fuel the market growth. Also, rise in number of older adults are becoming organ donors which expected to propel the market growth.
Market Restraints
However, high cost of molecular tests used for HLA typing procedures is the major restraining factor which is expected to hamper the global HLA typing for transplant market growth. Also, significant gap between the number of organ donors and organs required annually will affect the market growth.
Market Opportunity
Target research activities are expected to receive more public-private funding in the future, which will present the market with a number of expansion opportunities. Moreover, it is predicted that the market will benefit greatly from technological developments in the area of transplant diagnostics. The market for human leukocyte antigen (HLA) typing for transplants will continue to grow in the future due to a number of technological developments and the quick transition from serological assays to gene-based HLA typing.
Impact of Covid-19
The market for HLA typing for transplants is expected to be significantly impacted by the COVID-19 epidemic. The COVID-19 outbreak is being fought by pharmaceutical and biotech companies working with governments around the world on everything from vaccine development to contingency plans for problems with the pharmaceutical supply chain. The research and development pipeline is currently home to numerous vaccine candidates and substances. In addition, Hydroxychloroquine was widely used to stop COVID-19. Manufacturers of COVID-19 management medications have a lot of opportunities because there is such a high demand for these treatments that many wealthy nations are running out of them.
Segmentation By Type: Global HLA Typing For Transplant Market is classified on the basis of Type into Molecular Assays and Non-Molecular Assays.
Segmentation By Application: Global HLA Typing For Transplant Market on the basis of Application into Diagnostic Applications and Research Applications.
Segmentation By End-user: Global HLA Typing For Transplant Market on the basis of End-user into Hospitals & Transplant Centers, Commercial Service Providers, and Research Laboratories and Academic Institutes.
Segmentation By Region: Global HLA Typing For Transplant Market is classified on the basis of Region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Market Key Players
Various key players are discussed in this report such as THERMO FISHER SCIENTIFIC, F. HOFFMAN-LA ROCHE LIMITED, QIAGEN, IMMUCOR, ABBOTT LABORATORIES INC., CAREDX, INC., ILLUMINA, BIO-RAD LABORATORIES, ALPHA BIOTECH, LTD., and GENDX.
Industrial Development
• Thermo Fisher Scientific's One Lambda brand and Natera, Inc. (NASDAQ: NTRA), a pioneer in non-invasive genetic testing and the analysis of cell-free DNA, announced a partnership in February 2019 to jointly distribute Natera's kidney transplant rejection test in the United States. One Lambda is a world leader in human leukocyte antigen (HLA) typing and antibody monitoring assays for transplantation.
Market Taxonomy
By Type
• Molecular Assays
• Non-Molecular Assays
By Application
• Diagnostic Applications
• Research Applications
By End User
• Hospitals & Transplant Centers
• Commercial Service Providers
• Research Laboratories and Academic Institutes
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in HLA Typing For Transplant Market?
• What will be the growth rate from 2021 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?

Global HLA Typing For Transplant Market TOC:
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global HLA Typing For Transplant Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global HLA Typing For Transplant Market, By Type
5.1 Y-o-Y Growth Comparison, By Type 
5.2 Global HLA Typing For Transplant Market Share Analysis, By Type 
5.3 Global HLA Typing For Transplant Market Size and Forecast, By Type
5.3.1 Molecular Assays
5.3.2 Non-Molecular Assays
6  Global  HLA Typing For Transplant Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global HLA Typing For Transplant Market Share Analysis, By Application
6.3 Global HLA Typing For Transplant Market Size and Forecast, By Application
6.3.1 Diagnostic Application
6.3.2 Research Applications
7 Global HLA Typing For Transplant Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global HLA Typing For Transplant Market Share Analysis, By End User
7.3 Global HLA Typing For Transplant Market Size and Forecast, By End User
7.3. 1 Hospitals & Transplant Centres
7.3.2 Commercial Service Providers
7.3.3Research Laboratories & Academic Institutes
8 Global HLA Typing For Transplant Market, By Region
8.1 Global HLA Typing For Transplant Market Share Analysis, By Region
8.2 Global HLA Typing For Transplant Market Share Analysis, By Region
8.3 Global HLA Typing For Transplant Market Size and Forecast, By Region
9 North America HLA Typing For Transplant Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 North America HLA Typing For Transplant Market Share Analysis, By Type
9.3 North America HLA Typing For Transplant Market Size and Forecast, By Application
9.4 North America HLA Typing For Transplant Market Size and Forecast, By End User
9.5 North America HLA Typing For Transplant Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe HLA Typing For Transplant Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Europe HLA Typing For Transplant Market Share Analysis, By Type 
10.3 Europe HLA Typing For Transplant Market Size and Forecast, By Application 
10.4 Europe HLA Typing For Transplant Market Size and Forecast, By End User
10.5 Europe HLA Typing For Transplant Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11 Asia Pacific HLA Typing For Transplant Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Asia Pacific HLA Typing For Transplant Market Share Analysis, By Type 
11.3 Asia Pacific HLA Typing For Transplant Market Size and Forecast, By Application 
11.4 Asia Pacific HLA Typing For Transplant Market Size and Forecast, By End User
11.5 Asia Pacific HLA Typing For Transplant Market Size and Forecast, By Country
11.5.1 China 
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America HLA Typing For Transplant Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Latin America HLA Typing For Transplant Market Share Analysis, By Type 
12.3 Latin America HLA Typing For Transplant Market Size and Forecast, By Application 
12.4 Latin America HLA Typing For Transplant Market Size and Forecast, By End User
12.5 Latin America HLA Typing For Transplant Market Size and Forecast, Country
13 Middle East HLA Typing For Transplant Market Analysis and Forecast (2022 – 2027)
13.1 Introduction
13.2 Middle East HLA Typing For Transplant Market Share Analysis, By Type 
13.3 Middle East HLA Typing For Transplant Market Size and Forecast, By Application 
13.4 Middle East HLA Typing For Transplant Market Size and Forecast, By End User
13.5 Middle East HLA Typing For Transplant Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 THERMO FISHER SCIENTIFIC
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 F. HOFFMAN-LA ROCHE LIMITED
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 QIAGEN, IMMUCOR
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 ABBOTT LABORATORIES
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 CAREDX, INC
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 ILLUMINA
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7  BIO-RAD LABORATORIES
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies 
15.8 ALPHA BIOTECH
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies 
15.9 GENDX
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies